As to the article, a little diffuse. I would call it nonresponsive. Why was the price suddenly raised by a factor of six? I didn’t see that addressed. Maybe I missed it, which is entirely possible.
It mentioned the Obamacare medical device tax.
The author makes a few goods points about Clinton & Bernie and the medical device tax, but the ACA device tax would only account for about $5. of the increase. Basically, Ms. Bresch at Mylan got demand for the “Epipen” to jump dramatically by using her dad the U.S. senator to help push thru mandatory “epinephrine auto-injector” legislation for schools & airlines and also a lot of high-priced advertising to parents of allergic kids that they had to have Epipens. Unfortunately those parents/schools only think of “Epipen” when thinking of “epinephrine auto-injector”...sorta like Crescent wrench instead of “adjustable open-end wrench” or “Kleenex” instead of “tissue”. Sales skyrocketed and she jacked the price to match. Fortunately there are other suppliers of “epinephrine auto-injectors”....including “Adrenaclick” for about the cost of Epipen 10 years ago, and the usage instructions are very similar “remove safety caps, place needle end against the thigh and push firmly for 10 seconds”. :
http://www.goodrx.com/adrenaclick
Usage:
http://adrenaclick.com/how_to_use_adrenaclick_epinephrine_injection_USP_auto_injector.php
https://www.epipen.com/about-epipen/how-to-use-epipen
Their main competitor had a major recall. So they had the market cornered.